Quarterly report [Sections 13 or 15(d)]

Segment and Geographic Information - Summary of Significant Segment Expenses (Details)

v3.26.3
Segment and Geographic Information - Summary of Significant Segment Expenses (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Segment Reporting [Line Items]          
Revenue $ 74,081 $ 49,298 $ 213,971 $ 130,354  
Cost of revenue 57,261 38,644 167,819 103,640  
Gross profit 16,820 10,654 46,152 26,714  
Depreciation and amortization 1,801 1,081 5,263 2,764  
Less:          
Selling, general and administrative 15,140 15,912 44,741 41,534  
Amortization of intangible assets 5,511 364 13,624 1,128  
Operating loss from continuing operations (3,831) (5,622) (12,213) (15,948)  
Plus (less):          
Interest income, net 146 1,127 950 3,603  
Change in fair value of warrant liabilities 0 33 1,530 2,862  
Change in fair value of assets and other liabilities (2,649) 0 (4,715) 0  
Realized loss from sales of short-term investments (1,281) (5,195) (1,281) (5,195)  
Loss from continuing operations before income taxes (7,615) (9,657) (15,729) (14,678)  
Goodwill 101,918   101,918   $ 88,210
Logistics          
Segment Reporting [Line Items]          
Revenue 44,899 46,507 140,738 127,563  
Cost of revenue 35,564 36,517 113,350 101,513  
Gross profit 9,335 9,990 27,388 26,050  
Depreciation and amortization 1,329 965 3,893 2,572  
Plus (less):          
Goodwill 15,540   15,540   15,540
Clinical          
Segment Reporting [Line Items]          
Revenue 29,182 2,791 73,233 2,791  
Cost of revenue 21,697 2,127 54,469 2,127  
Gross profit 7,485 664 18,764 664  
Depreciation and amortization 382 $ 58 1,112 $ 58  
Plus (less):          
Goodwill $ 86,378   $ 86,378   $ 72,670